Single-Site-Specific Cysteine Arylation Directed by A Genetically Encodable Pi-Clamp

Exclusively Licensed

Disclosed are methods of single-site-specific cysteine modification on peptide/protein molecules under physiologically relevant conditions. This process features several significant advantages over existing methods of peptide modification, such as specificity towards thiols over other nucleophiles (e.g., amines, hydroxyls), excellent functional group tolerance, and mild reaction conditions. Especially important is the specificity observed for thiols appearing in an X-Cys-Pro-X sequence over other thiols or disulfides, where X is Phe, Trp, or Tyr; under the inventive conditions, other cysteines or reactive functional groups on the same peptide/protein chain are not functionalized.

Researchers

Bradley L. Pentelute / Peng Dai / Chi Zhang

Departments: Department of Chemistry
Technology Areas: Biotechnology: Synthetic Biology / Diagnostics: Assays / Drug Discovery and Research Tools: Cell Interrogation, Genomics & Proteomics
Impact Areas: Healthy Living

  • single-site-specific cysteine arylation directed by a genetically encodable pi-clamp
    United States of America | Granted | 9,181,297

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies